IL4R and Alzheimer disease: Single-cell RNA sequencing of skin lesions from patients with AD who underwent long-term treatment with the IL-4Rα blocker dupilumab demonstrated that transcriptomic dysregulation in keratinocytes was completely normalized, whereas the AD signature in dendritic cells (DCs) and T lymphocytes persisted for up to a year after clinical remission (11).